In summary, BRD4 can serve as an effective target for treating hepatic fibrosis, and BRD4 inhibition can significantly attenuate the progression of hepatic fibrosis through TGF-β, inflammation and other signaling pathways [Fig. 6]. Here, BRD4 is linked to Hepatic fibrosis.